Purity

Anti-DLL3 Reference Antibody (rovalpituzumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

SEC-HPLC

The purity of Anti-DLL3 Reference Antibody (rovalpituzumab) is 98.44%, determined by SEC-HPLC.

ELISA

Immobilized human DLL3 His at 2 ug/mL can bind Anti-DLL3 Reference Antibody (rovalpituzumab), EC50=0.01407 ug/mL.

FACS

Human DLL3 HEK293 cells were stained with Anti-DLL3 Reference Antibody (rovalpituzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.01586 ug/mL.

-25~-15℃保存，有效期1年。